OTC derivatives valuation and risk analysis advisory service as a third-party firm in a neutral position. Provides fairness opinions on derivatives proposed by investment banks.
Clients: Financial institutions like commercial banks as an investor.
Competitors: Investment banks as a structured products provider.
Showing posts with label Financial Industry. Show all posts
Showing posts with label Financial Industry. Show all posts
Tuesday, December 28, 2010
Subscribe to:
Posts (Atom)